|
“Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H1 2013″ Is …
SBWire (press release) This report provides information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the … Remote people face heightened kidney riskNinemsn |
Study Evaluating REVLIMID® Combination Compared to Autologous Stem Cell … – Business Wire (press release)
|
Study Evaluating REVLIMID® Combination Compared to Autologous Stem Cell …
Business Wire (press release) … today announced data from a study comparing melphalan, prednisone and REVLIMID (lenalidomide) (MPR) with high-dose chemotherapy and tandem autologous stem cell transplant (MEL200), as well as evaluating the effect of lenalidomide maintenance … ASCO 2013 Multiple Myeloma Update – Day Two: Education SessionThe Myeloma Beacon |
Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell … – MarketWatch (press release)
|
Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell …
MarketWatch (press release) Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell Transplant with or without REVLIMID Maintenance in Newly-Diagnosed Multiple Myeloma Presented at ASCO. MEL200 demonstrated a longer median PFS and OS compared … ASCO 2013 Multiple Myeloma Update – Day Two: Education SessionThe Myeloma Beacon |
Israeli child's donated kidney saves Palestinian boy – Israel Today
|
Israeli child’s donated kidney saves Palestinian boy
Israel Today … the Times of Israel. Naom’s father told Israel’s News1 that for he and his wife, it made no difference that the recipient of their son’s kidney was a Palestinian Arab. PHOTO: 3-year-old Noam Naor, who tragically suffered brain death after falling … |
Blood donation opportunities with American Red Cross – fox6now.com
|
Blood donation opportunities with American Red Cross
fox6now.com MILWAUKEE (WITI) — The American Red Cross encourages eligible donors to give blood this summer, helping to ensure a sufficient supply for patients in need and allowing them to create their summer of stories. Below are just a few examples of patients … Red Cross explains blood donation processStanly News & Press Red Cross Blood Drive Becoming New RiverFest TraditionKAKE |
TG Therapeutics, Inc. Announces Presentation of Interim Results From Its Phase … – NASDAQ (press release)
|
TG Therapeutics, Inc. Announces Presentation of Interim Results From Its Phase …
NASDAQ (press release) NEW YORK, June 3, 2013 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. ( TGTX ) today announced preliminary results from a Phase 1 clinical study of single-agent ublituximab (TG-1101) in patients with rituximab relapsed and/or refractory Non-Hodgkin’s … |
TG Therapeutics , Inc . Announces Presentation of Interim Results From Its … – MarketWatch
|
TG Therapeutics , Inc . Announces Presentation of Interim Results From Its …
MarketWatch TG Therapeutics, Inc. (TGTX) today announced preliminary results from a Phase 1 clinical study of single-agent ublituximab (TG-1101) in patients with rituximab relapsed and/or refractory Non-Hodgkin’s Lymphoma (NHL), presented at the American Society … |
The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for … – 7thSpace Interactive (press release)
The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for …7thSpace Interactive (press release)We further hypothesized that treatment with cyclosporine A, a Pgp1 inhibitor, would render cells more sensitive to treatment with corticost…
INTERNATIONAL > Human rights body calls on int'l sister bodies for … – Hurriyet Daily News
|
INTERNATIONAL > Human rights body calls on int’l sister bodies for …
Hurriyet Daily News When asked whether he was in a position to confirm these reports, Bakkalcı referred to the written statement by the TİHV which said, “There are extremely persuasive and strong claims about brain death of a young person of ours in Ankara as of last … |
Scientists develop new method for finding therapeutic antibodies – domain-B
Scientists develop new method for finding therapeutic antibodiesdomain-BScientists at The Scripps Research Institute (TSRI) at La Jolla, California, have devised a powerful new technique for finding antibodies that have a desired biological effect. Ant…